We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
You must tell DVLA if you have obstructive sleep apnoea syndrome (OSAS) or any sleep condition or apnoea which causes excessive sleepiness.
Looking into how some factors that can influence the performance of people on board can lead to more accidents as well as how to mitigate or control these factors.
Advice for medical professionals to follow when assessing drivers with neurological disorders.
Facts about driving and tiredness when you have a medical condition.
Advice for medical professionals to follow when assessing drivers with miscellaneous conditions.
Find out about the long-term effects some people can have after having COVID-19.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
If you have long COVID there is a range of support available.
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).